Personalis (NASDAQ:PSNL) Updates Q4 2021 Earnings Guidance

Personalis (NASDAQ:PSNL) updated its fourth quarter 2021 earnings guidance on Thursday. The company provided earnings per share guidance of $-0.510-$-0.490 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-0.490. The company issued revenue guidance of $20.20 million-$20.40 million, compared to the consensus revenue estimate of $20.39 million.Personalis also updated its FY 2021 guidance to $-1.510-$-1.490 EPS.

Several equities research analysts have commented on the company. Citigroup dropped their target price on Personalis from $37.00 to $30.00 and set a buy rating on the stock in a report on Thursday, August 5th. Needham & Company LLC downgraded Personalis from a buy rating to a hold rating in a report on Wednesday, November 3rd. BTIG Research reissued a buy rating and issued a $29.00 target price on shares of Personalis in a report on Friday, November 5th. Zacks Investment Research downgraded Personalis from a hold rating to a sell rating in a report on Thursday, November 11th. Finally, HC Wainwright reissued a buy rating and issued a $50.00 target price on shares of Personalis in a report on Thursday, September 23rd. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of Hold and a consensus price target of $34.90.

Shares of PSNL stock traded up $0.56 during mid-day trading on Thursday, hitting $14.51. The company’s stock had a trading volume of 311,041 shares, compared to its average volume of 652,979. Personalis has a 52-week low of $13.40 and a 52-week high of $53.46. The business has a 50-day moving average price of $18.83 and a 200 day moving average price of $20.74. The stock has a market cap of $649.82 million, a price-to-earnings ratio of -10.59 and a beta of 1.45.

Personalis (NASDAQ:PSNL) last posted its quarterly earnings results on Thursday, November 4th. The company reported ($0.40) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.40). Personalis had a negative return on equity of 19.34% and a negative net margin of 68.68%. During the same period in the previous year, the company earned ($0.27) earnings per share. As a group, equities research analysts predict that Personalis will post -1.54 EPS for the current fiscal year.

In related news, CEO John Stephen West sold 100,000 shares of the company’s stock in a transaction on Tuesday, October 12th. The stock was sold at an average price of $19.33, for a total transaction of $1,933,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Aaron Tachibana sold 3,820 shares of the company’s stock in a transaction dated Thursday, September 2nd. The stock was sold at an average price of $21.92, for a total value of $83,734.40. The disclosure for this sale can be found here. In the last quarter, insiders have sold 111,952 shares of company stock valued at $2,174,574. 7.50% of the stock is owned by company insiders.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Invesco Ltd. increased its position in Personalis by 12.5% in the third quarter. Invesco Ltd. now owns 17,720 shares of the company’s stock worth $340,000 after buying an additional 1,971 shares in the last quarter. BNP Paribas Arbitrage SA boosted its stake in shares of Personalis by 133.5% in the third quarter. BNP Paribas Arbitrage SA now owns 9,057 shares of the company’s stock worth $174,000 after acquiring an additional 5,178 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Personalis by 14.9% in the third quarter. Bank of New York Mellon Corp now owns 124,962 shares of the company’s stock worth $2,404,000 after acquiring an additional 16,174 shares during the period. Finally, Wells Fargo & Company MN boosted its stake in shares of Personalis by 97.4% in the second quarter. Wells Fargo & Company MN now owns 45,492 shares of the company’s stock worth $1,152,000 after acquiring an additional 22,446 shares during the period. Institutional investors and hedge funds own 68.52% of the company’s stock.

About Personalis

Personalis, Inc engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.

Featured Story: Why Invest in Dividend Kings

Earnings History and Estimates for Personalis (NASDAQ:PSNL)

Receive News & Ratings for Personalis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Personalis and related companies with MarketBeat.com's FREE daily email newsletter.